Bristol Myers Squibb to Participate in Morgan Stanley’s 18th Annual Global Healthcare Virtual Conference

NEW YORK--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today announced that the company will take part in a fireside chat at Morgan Stanley’s 18th Annual Global Healthcare Virtual Conference, which will be webcast on Thursday, September 17, 2020. Giovanni Caforio, M.D., Chairman and Chief Executive Officer will answer questions about the company at 1:15 p.m. EDT.

Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. An archived edition of the session will be available later that day.

About Bristol Myers Squibb

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.

corporatefinancial-news